Healthcare and prescription medication affordability in adults with diabetes in the United States, 2020–2023
Authors' conclusion
Adults with diabetes face challenges in healthcare and prescription medication affordability compared to those without diabetes and the general population, particularly evident among nonelderly adults.
Study context
- Population
- US adults, National Health Interview Survey 2020–2023; 9.6 % reported diabetesweighted 253 million
- Participants
- 117,536 adults
- Exposure
- Adults with diabetes vs without diabetes / general US adult population
- Outcome
- Healthcare and prescription medication affordability
Methodological detailsUS National Health Interview Survey 2020-2023
- US National Health Interview Survey 2020-2023
Main finding
As reported in the abstract
Inability to pay medical bills (diabetes)
Diabetes
11.4 %
CI 10.7-12.1 %
- Estimated individuals with diabetes unable to pay medical bills
- 2.7 million
Observational data: associations, not effects.
Further findings
%
| Outcome | Diabetes | General US adult population |
|---|---|---|
| Cost-related medication nonadherence | 14.3 (CI 13.5-15.1 %) | 9.6 (CI 9.3-9.9 %) |
- Cost-related medication nonadherence: 95 % CI
Cost-related medication nonadherence
- Independently correlated with nonadherence: age <65 years, female, low income, South or West region, higher comorbidity burden, lack of insurance
Original publication
Healthcare and prescription medication affordability in adults with diabetes in the United States, 2020–2023. Diabetes Res Clin Pract. Published 24 June 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →